The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125111042 12511104 2 F 20160718 20160629 20160728 EXP US-MYLANLABS-2016M1026433 MYLAN 0.00 Y 0.00000 20160728 PH US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125111042 12511104 1 PS Clozapine Tablets, USP CLOZAPINE 1 Oral 100 MG, HS U 75417 100 MG TABLET QD
125111042 12511104 2 SS Clozapine Tablets, USP CLOZAPINE 1 Oral 25 MG, AM U 75417 25 MG TABLET QD
125111042 12511104 3 SS LITHIUM. LITHIUM 1 Oral 300 MG, BID Y U 0 300 MG BID
125111042 12511104 4 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 325 MG, Q6H, PRN 0 325 MG Q6H
125111042 12511104 5 C ACETAMINOPHEN. ACETAMINOPHEN 1 0
125111042 12511104 6 C MYLANTA ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE 1 Oral 30 ML, QD, PRN 0 30 ML QD
125111042 12511104 7 C AUGMENTIN AMOXICILLINCLAVULANATE POTASSIUM 1 Oral 875/125 MG, BID 0 875 MG BID
125111042 12511104 8 C AZITHROMYCIN ANHYDROUS. AZITHROMYCIN ANHYDROUS 1 Oral 250 MG, QD 0 250 MG QD
125111042 12511104 9 C BENZTROPINE BENZTROPINE 1 Oral 2 MG, TID 0 2 MG TID
125111042 12511104 10 C TRAZODONE TRAZODONE HYDROCHLORIDE 1 0
125111042 12511104 11 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 0
125111042 12511104 12 C FLUPHENAZINE FLUPHENAZINE 1 Oral 25 MG, HS 0 25 MG QD
125111042 12511104 13 C HYDRALAZINE HYDRALAZINE HYDROCHLORIDE 1 Oral 25 MG, TID 0 25 MG TID
125111042 12511104 14 C NOVOLOG INSULIN ASPART 1 SLIDING SCALE 0
125111042 12511104 15 C LACTINEX /00079701/ 2 1 DF, QD 0 1 DF QD
125111042 12511104 16 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 50 ?G, QD 0 50 UG QD
125111042 12511104 17 C VERAPAMIL VERAPAMIL HYDROCHLORIDE 1 240 MG, QD 0 240 MG QD
125111042 12511104 18 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 500 MG, BID 0 500 MG BID
125111042 12511104 19 C METOPROLOL. METOPROLOL 1 Oral 50 MG, BID 0 50 MG BID
125111042 12511104 20 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 8 MG, Q8H, PRN 0 8 MG Q8H
125111042 12511104 21 C MIRALAX POLYETHYLENE GLYCOL 3350 1 Oral 17 G, QD, PRN 0 17 G QD
125111042 12511104 22 C SENNA S DOCUSATE SODIUMSENNA LEAF 1 Oral 2 DF, BID 0 2 DF BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125111042 12511104 3 Affective disorder
125111042 12511104 4 Pain
125111042 12511104 5 Pyrexia
125111042 12511104 6 Dyspepsia
125111042 12511104 20 Vomiting
125111042 12511104 21 Constipation

Outcome of event

Event ID CASEID OUTC COD
125111042 12511104 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125111042 12511104 Dehydration
125111042 12511104 Pneumonia
125111042 12511104 Toxicity to various agents
125111042 12511104 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125111042 12511104 3 2016 0